Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 656 participants.

Also called NCT01220622

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 656 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01220622
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01220622. Randomized; quadruple masking; primary purpose prevention. Start 2010-10 (registry gives no type); primary completion 2012-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety Study of Nimodipine to Prevent Mild Cognitive Impairment After Acute Ischemic Strokes
Acronym
NICE
Condition
Stroke
Condition
Mild Cognitive Impairment
Intervention (Drug)
Nimodipine
Intervention (Drug)
Placebo
Lead sponsor
Ministry of Science and Technology of the People´s Republic of China (class: other government)

Record details

Record id
cardio:ct-nct01220622
Content hash
b805d600a3824005cb2d087b9d8eadea958ee9e124e8153bf7d5bd96029f285a